Login / Signup

Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease.

Trevor L SchellKeith L KnutsonSumona SahaArnold WaldHiep S PhanMazen AlmasryKelly ChunIan GrimesMegan LutzMary S HayneyFrancis A FarrayeFreddy Caldera
Published in: Inflammatory bowel diseases (2022)
Keyphrases
  • patients with inflammatory bowel disease
  • coronavirus disease
  • sars cov
  • immune response
  • respiratory syndrome coronavirus
  • nucleic acid